Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...
Novo Nordisk announced that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients.
Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback